Skip to content
HowShorted

TENET HEALTHCARE CORP short interest in 2018

In 2018, TENET HEALTHCARE CORP's disclosed short interest ran from 29.14% of shares outstanding on 12 Jan 2018 to 10.26% on 31 Dec 2018, a change of -18.88 percentage points. The year's high was 29.14% on 12 Jan 2018 and its low 9.41% on 14 Dec 2018, averaging 15.74% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.90 days on 28 Sep 2018. Full history: TENET HEALTHCARE CORP.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for TENET HEALTHCARE CORP in 2018

2018 in figures

Start of year
29.14% (12 Jan 2018)
End of year
10.26% (31 Dec 2018)
Change
-18.88 pp
High
29.14% (12 Jan 2018)
Low
9.41% (14 Dec 2018)
Average
15.74%
Highest days to cover
14.90 (28 Sep 2018)
SEC filings marked
8

Every report in 2018

TENET HEALTHCARE CORP short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 201829.14%12.77
31 Jan 201824.63%8.86
15 Feb 201824.43%11.54
28 Feb 201823.59%8.4510-K filed, results (8-K)
15 Mar 201821.26%7.95
29 Mar 201820.63%9.00
13 Apr 201818.36%9.53
30 Apr 201816.96%10.3610-Q filed, results (8-K)
15 May 201815.34%4.94
31 May 201815.35%8.74
15 Jun 201813.31%9.40
29 Jun 201812.34%8.60
13 Jul 201812.62%11.67
31 Jul 201813.07%7.33
15 Aug 201812.22%6.1210-Q filed, results (8-K)
31 Aug 201812.15%10.30
14 Sep 201813.18%11.19
28 Sep 201813.66%14.90
15 Oct 201813.82%8.98
31 Oct 201812.55%13.61
15 Nov 20189.87%5.6610-Q filed, results (8-K)
30 Nov 20189.65%7.81
14 Dec 20189.41%7.62
31 Dec 201810.26%6.60

See also: TENET HEALTHCARE CORP's full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.